US Bancorp’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.2K Buy
3,794
+3,074
+427% +$19.6K ﹤0.01% 3098
2025
Q1
$3.5K Buy
720
+455
+172% +$2.21K ﹤0.01% 3737
2024
Q4
$2.53K Hold
265
﹤0.01% 3807
2024
Q3
$2.21K Hold
265
﹤0.01% 3751
2024
Q2
$1.81K Hold
265
﹤0.01% 3714
2024
Q1
$670 Sell
265
-351
-57% -$887 ﹤0.01% 3829
2023
Q4
$1.48K Sell
616
-62
-9% -$149 ﹤0.01% 3737
2023
Q3
$2.31K Sell
678
-174
-20% -$592 ﹤0.01% 3613
2023
Q2
$6.26K Sell
852
-1,306
-61% -$9.6K ﹤0.01% 3388
2023
Q1
$22.4K Sell
2,158
-1,720
-44% -$17.8K ﹤0.01% 2926
2022
Q4
$45.8K Sell
3,878
-925
-19% -$10.9K ﹤0.01% 2572
2022
Q3
$101K Buy
4,803
+1,213
+34% +$25.5K ﹤0.01% 2184
2022
Q2
$112K Sell
3,590
-1,061
-23% -$33.1K ﹤0.01% 2170
2022
Q1
$191K Sell
4,651
-1,575
-25% -$64.7K ﹤0.01% 1964
2021
Q4
$271K Buy
6,226
+1,495
+32% +$65.1K ﹤0.01% 1830
2021
Q3
$237K Buy
4,731
+81
+2% +$4.06K ﹤0.01% 1882
2021
Q2
$293K Sell
4,650
-3,608
-44% -$227K ﹤0.01% 1813
2021
Q1
$767K Sell
8,258
-4,633
-36% -$430K ﹤0.01% 1278
2020
Q4
$1.16M Buy
12,891
+3,997
+45% +$358K ﹤0.01% 1039
2020
Q3
$919K Buy
8,894
+3,588
+68% +$371K ﹤0.01% 1040
2020
Q2
$419K Sell
5,306
-1,096
-17% -$86.5K ﹤0.01% 1390
2020
Q1
$370K Sell
6,402
-1,118
-15% -$64.6K ﹤0.01% 1362
2019
Q4
$405K Sell
7,520
-304
-4% -$16.4K ﹤0.01% 1474
2019
Q3
$409K Sell
7,824
-2,031
-21% -$106K ﹤0.01% 1468
2019
Q2
$476K Sell
9,855
-13,319
-57% -$643K ﹤0.01% 1427
2019
Q1
$1.17M Buy
23,174
+1,221
+6% +$61.7K ﹤0.01% 994
2018
Q4
$1.3M Sell
21,953
-2,104
-9% -$125K ﹤0.01% 892
2018
Q3
$1.58M Sell
24,057
-1,268
-5% -$83.4K ﹤0.01% 904
2018
Q2
$1.28M Sell
25,325
-1,760
-6% -$88.7K ﹤0.01% 988
2018
Q1
$1.43M Sell
27,085
-1,493
-5% -$78.6K ﹤0.01% 930
2017
Q4
$1.33M Sell
28,578
-8,920
-24% -$415K ﹤0.01% 968
2017
Q3
$1.52M Sell
37,498
-3,192
-8% -$129K ﹤0.01% 898
2017
Q2
$1.38M Sell
40,690
-295
-0.7% -$10K ﹤0.01% 919
2017
Q1
$1.19M Buy
40,985
+4,398
+12% +$128K ﹤0.01% 993
2016
Q4
$1.2M Sell
36,587
-8,430
-19% -$277K ﹤0.01% 972
2016
Q3
$1.42M Buy
45,017
+12,439
+38% +$392K 0.01% 865
2016
Q2
$916K Buy
32,578
+2,839
+10% +$79.8K ﹤0.01% 1046
2016
Q1
$1.08M Sell
29,739
-3,430
-10% -$125K ﹤0.01% 937
2015
Q4
$1.33M Buy
33,169
+2,152
+7% +$86.1K 0.01% 833
2015
Q3
$884K Buy
31,017
+6,166
+25% +$176K ﹤0.01% 1034
2015
Q2
$819K Buy
24,851
+1,303
+6% +$42.9K ﹤0.01% 1128
2015
Q1
$677K Buy
23,548
+2,541
+12% +$73.1K ﹤0.01% 1207
2014
Q4
$572K Buy
21,007
+2,978
+17% +$81.1K ﹤0.01% 1275
2014
Q3
$385K Buy
18,029
+2,872
+19% +$61.3K ﹤0.01% 1452
2014
Q2
$340K Buy
15,157
+3,233
+27% +$72.5K ﹤0.01% 1549
2014
Q1
$301K Buy
+11,924
New +$301K ﹤0.01% 1562